Tag: recent medicare fraud cases

2019 outlook: Lab industry future looks dire, from reactions to recent Medicare fraud cases to PAMA reporting and other stress factors

By Mary Van Doren, from the Volume XXV No. 18 – December 24, 2018 issue

CEO SUMMARY: This year’s list of the Top 10 Lab Industry Stories for 2018 is dominated by new directives from Medicare and private health insurers, as well as significant decisions by federal courts. Collectively, these developments create new compliance risks for all clinical laboratories and anatomic pathology groups. What is more notable about these top

View Article

Volume XXVI No. 1 – January 14, 2019

LAB ADMINISTRATORS AND PATHOLOGISTS should pay close attention to emerging new disruptive forces outlined in this issue -- and their potential to upend the clinical laboratory industry as it exists today. From slashed Medicare prices, to the risk of $10,000-per-day penalties for PAMA price-reporting errors, to narrowing networks, 2019 will be one of the most challenging years facing the clinical lab industry since the early 1990s. At the same time, THE DARK REPORT details five specific strategies from a highly-respected lab industry executive that administrators can leverage to survive and thrive in the storm.

See the full table of contents

Tag: recent medicare fraud cases

Enter Your Login Credentials